Published in AIDS Weekly, March 20th, 2000
Scientists have devised for the first time an HIV vaccine using a weakened rabies virus to carry a piece of the HIV "coat" into a cell. In rousing the body into making anti-HIV antibodies, they may have found a way to effectively turn on the immune system against the virus. The work, which for now is limited to tests in mice, lends hope to eventually designing such a vaccine against HIV in humans.
The researchers, led by Matthias Schnell, PhD, assistant professor of biochemistry and molecular pharmacology, and Roger...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2000-03-20)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.